VALENCIA FIRM IN BATTLE AGAINST BIOTERROISM.Byline: Daily News SANTA CLARITA - With anthrax anthrax (ăn`thrăks), acute infectious disease of animals that can be secondarily transmitted to humans. It is caused by a bacterium (Bacillus anthracis contamination spreading in government buildings, a Valencia company is researching ways to reduce or eliminate potential anthrax bacteria and smallpox from ventilation systems and other carriers. UltraViolet Devices Inc., which builds systems that disinfect To remove the virus code that has attached itself to a legitimate file. Sometimes, the antivirus program cannot untangle the code, and the infected file has to be deleted. See quarantine. air and water, began working before the Sept. 11 terrorist attacks on ways to battle biological hazards. It is researching the amount of ultraviolet energy necessary to combat a bacterial threat. ``We are working on coming up with a sound position on how UV could help the air quality with the times we live in today,'' said Gene Doucette, sales manager with UltraViolet Devices Inc. ``It's just not as simple as coming up with an answer. We are just in the process of doing that work.'' In the past two years, the company has worked with Pennsylvania State University Pennsylvania State University, main campus at University Park, State College; land-grant and state supported; coeducational; chartered 1855, opened 1859 as Farmers' High School. in developing software that uses heating, ventilation and air conditioning systems to utilize a variety of germicidal germicidal /ger·mi·ci·dal/ (jer?mi-si´d'l) antimicrobial (1). germicidal destructive to pathogenic microorganisms. ultraviolet light Ultraviolet light A portion of the light spectrum not visible to the eye. Two bands of the UV spectrum, UVA and UVB, are used to treat psoriasis and other skin diseases. strategies. This software incorporates numerous variables to predict ``kill-rates'' for airborne pathogens including microorganisms responsible for anthrax and the virus responsible for smallpox, said Dave Witham, vice president of technology. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion